Amy J. Ramsey

Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition.

Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter.

Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.

Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction.

Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling.

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.

Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner.

Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum.

Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.

D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.

Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling.

N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo.

Diazepam improves aspects of social behaviour and neuron activation in NMDA receptor deficient mice.